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Abstract: Nanoparticles that are aimed at targeting cancer cells, but sparing healthy tissue provide
an attractive platform of implementation for hyperthermia or as carriers of chemotherapeutics.
According to the literature, diverse effects of nanoparticles relating to mammalian reproductive
tissue are described. To address the impact of nanoparticles on cyto- and genotoxicity concerning
the reproductive system, we examined the effect of superparamagnetic iron oxide nanoparticles
(SPIONs) on granulosa cells, which are very important for ovarian function and female fertility.
Human granulosa cells (HLG-5) were treated with SPIONs, either coated with lauric acid (SEONLA)
only, or additionally with a protein corona of bovine serum albumin (BSA; SEONLA-BSA), or
with dextran (SEONDEX). Both micronuclei testing and the detection of γH2A.X revealed no
genotoxic effects of SEONLA-BSA, SEONDEX or SEONLA. Thus, it was demonstrated that different
coatings of SPIONs improve biocompatibility, especially in terms of genotoxicity towards cells of
the reproductive system.
Keywords: superparamagnetic iron oxide nanoparticles; protein corona; cancer therapy and diagnosis;
reproductive health; granulosa cells
1. Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) have been widely investigated for many
years now. Due to their exceptional magnetic, electronic and optical properties, they have turned out
to be promising candidates for research and future use in an industrial or clinical setting. Especially
for medical and scientific applications ranging from in vitro diagnostic tests, in vivo imaging, targeted
drug delivery and tissue regeneration, SPIONs are capable candidates.
In particular, SPION-based contrast enhancement in magnetic resonance imaging (MRI) [1],
magnetic hyperthermia treatment [2] and magnetic drug targeting (MDT) [3,4] are of special interest
in the therapy and diagnosis of cancer and other diseases [3,5]. Their incorporation into therapeutic
drugs and their parallel use in imaging processes enables SPIONs to become “theranostic” agents.
Additionally, the use of SPIONs in magnetic tissue engineering is a new concept in biomedicine [6].
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SPIONs usually consist of iron oxide cores measuring 5–20 nm in diameter made of
magnetite (Fe3O4) and its oxidized form maghemite (γ-Fe2O3). To increase their colloidal
stability and biocompatibility, these iron oxide cores are coated with, e.g., long-chain fatty
acids [7] or biocompatible polymers as chitosan or dextran [8]. Commercially accessible contrast
agents like Sinerem, Resovist, Supravist and Ferridex have a surface coating of dextran or
carboxydextran [9]. The formation of a surrounding protein corona also contributes to the
stabilization and biocompatibility of iron oxide nanoparticles [10].
Because of the highly catalytic properties of nanoparticle surfaces [11,12], their coating may work
as a barrier and could reduce their toxic potential. Especially for iron oxide nanoparticles, Fenton-like
reactions caused by released iron ions [13] or on the nanoparticle surface have been under discussion
as triggering toxic effects [14]. Here, hydroxyl radicals are generated which are highly reactive and
react with almost all cellular macromolecules such as lipids, proteins, and carbohydrates. Since
nanotoxicity has been identified as being a tiered process starting with oxidative stress, the oxidation
of cellular components may finally result in cell death [12]. It is an important fact that oxidative stress
has also been identified as causing DNA damage such as abasic DNA sites, oxidized bases along with
single and double strand DNA breaks [15].
For the future translation of SPIONs from bench to bedside, it is crucial to evaluate their
biocompatibility and exclude potential toxic effects. Only few studies have focused to date on
the effect of nanoparticles on reproductive cells. Since iron oxide nanoparticles have previously
been shown to cross the placenta and accumulate in the fetus [16], applied medical nanoparticles
must be absolutely biocompatible and safe. Here, granulosa cells are used as a model system for
female reproductive tissue. These cells play a key role in sustaining ovarian function, health and
female fertility and, are thus closely associated with the development of the female gamete. In
this study, we compare the effect of SPIONs which were coated with different surface moieties.
The first two systems, SEONLA and SEONLA-BSA derive from the same coprecipitation synthesis
where the particles are stabilized in situ by a double layer of lauric acid [17]. The difference is
that SEONLA-BSA is additionally coated with a BSA shell, which greatly improves colloidal stability,
influences biocompatibility and enhances its capacity for drug loading. In a recent, detailed study,
we comprehensively characterized the properties of these two systems [10]. The third system is
synthesized also by coprecipitation, but a different surface coating strategy was chosen: SEONDEX
particles are directly precipitated in dextran containing iron solution. This enables narrow core
size distribution and high colloidal stability by steric stabilization. These particles have also been
comprehensively characterized earlier [18]. As an important aspect, we demonstrated that the
appropriate coating of iron oxide nanoparticles ensures their biocompatibility.
2. Results and Discussion
2.1. Uptake of Iron Oxide Nanoparticles by Granulosa Cells
Nanoparticle-induced toxicity is highly correlated with cellular uptake. Therefore, we measured
the cellular iron content on equal terms as in toxicity tests. Granulosa cells were incubated for 48 h
with three different superparamagnetic iron oxide nanoparticles: SEONLA (coated with lauric acid
only), SEONLA-BSA (coated with lauric acid and albumin) and SEONDEX (coated with dextran). After
incubation, the cells were washed and the amount of iron was subsequently analyzed from cell
lysates by microwave plasma atomic emission spectroscopy (MP-AES). Evaluation of cellular iron
content indicated that SEONLA were effectively taken up by cells, whereas SEONLA-BSA were only
weakly taken up and SEONDEX not at all (Figure 1). These results are in concordance with previous
investigations on uptake of SEON nanoparticles by primary human umbilical vein endothelial cells
(HUVEC) and by T-cells (Jurkat) [19,20]. Other groups also showed that cellular uptake efficiency of
iron oxide nanoparticles is dependent on surface coating and the protein corona [21,22]. To sum up,
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the presence of a pre-formed albumin protein corona (SEONLA-BSA) reduces cellular uptake of the
SEON particles remarkably compared to particles stabilized only by a lauric acid layer (SEONLA).
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Figure 1. Uptake of SPIONs by HLG-5 cells. Cells were incubated with 50, 100 or 150 μg/mL of (a) SEONLA; 
(b) SEONLA-BSA; or (c) SEONDEX for 48 h. The cellular iron content was analyzed from cell lysates by 
microwave plasma atomic emission spectroscopy (MP-AES). The mean values of n = 3 with standard 
deviations are shown. 
2.2. Viability of Granulosa Cells after Incubation with SPION 
Viability of HLG-5 granulosa cells was determined using flow cytometry. The cells were stained 
for phosphatidylserine exposure using Annexin V-Fitc (AxV) and plasma membrane integrity using 
propidium iodide (PI). AxV/PI data were confirmed by staining for mitochondrial membrane 
potential using DiIC1(5) (data not shown) according to Munoz et al. [23]. AxV/PI staining showed that 
SEONLA-BSA and SEONDEX did not induce any cytotoxicity up to a tested concentration of 150 μg/mL, 
whereas SEONLA induced cell death starting at 100 μg/mL (Figure 2). The rate of necrotic cells 
increased in a dose-dependent manner in SEONLA-treated cells. 
 
Figure 2. Cell death induction in HLG-5 cells. Cells were incubated with 50, 100, 150 μg/mL SPIONs for 
48 h. Etoposide-treated cells served as positive control; mock treated cells served as negative control. 
Cell viability was determined by AnnexinV-Fitc/propidium iodide (AxV/PI) staining. AxV-/PI- cells 
are considered viable, AxV+/PI- are apoptotic, and PI+ cells are necrotic. The mean values of n = 3 
with standard deviations are shown. 
As granulosa cells do not only protect the oocyte physically, but are furthermore very important 
for development, toxic effects of nanoparticles on these cells might be accompanied by reduced 
fertility or congenital defects. Although only few studies have focused on the effect of nanoparticles 
on reproductive cells to date, it has been demonstrated so far that magnetic nanoparticles do not 
Figure 1. Uptake of SPIONs by HLG-5 cells. Cells were incubated with 50, 100 or 150 µg/mL of (a)
SEONLA; (b) SEONLA-BSA; or (c) SEONDEX for 48 h. The cellular iron content was analyzed from cell
lysates by microwave plasma atomic emission spectroscopy (MP-AES). The mean values of n = 3 with
standard deviations are shown.
2.2. Viability of Granulosa Cells after Incubation with SPION
Viability of HLG-5 granulosa cells was determined using flow cytometry. The cells were
stained for phosphatidylserine exposure using Annexin V-Fitc (AxV) and plasma membrane integrity
using propidium iodide (PI). AxV/PI data were confirmed by staining for mitochondrial membrane
potential using DiIC1(5) (data not shown) according to Munoz et al. [23]. AxV/PI staining showed
that SEONLA-BSA and SEONDEX did not induce any cytotoxicity up to a tested concentration of
150 µg/mL, whereas SEONLA induced cell death starting at 100 µg/mL (Figure 2). The rate of necrotic
cells increased in a dose-dependent manner in SEONLA-treated cells.
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Figure 2. Cell death induction in HLG-5 cells. Cells were incubated with 50, 100, 150 µg/mL
SPIONs for 48 h. Etoposide-treated cells served as positive control; mock treated cells served
as negative control. Cell viability was determined by AnnexinV-Fitc/propidium iodide (AxV/PI)
staining. AxV-/PI- cells are con idered viable, AxV+/PI- are apoptotic, and PI+ cells are necrotic. The
mean values of n = 3 with standard deviations are shown.
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As granulosa cells do not only protect the oocyte physically, but are furthermore very important
for development, toxic effects of nanoparticles on these cells might be accompanied by reduced
fertility or congenital defects. Although only few studies have focused on the effect of nanoparticles
on reproductive cells to date, it has been demonstrated so far that magnetic nanoparticles do not
affect functionality [24], whereas ZnO and TiO2 nanoparticles may have toxic effects on male gametes
depending on their concentration and composition, and can affect sperm cell functionality [25].
Concerning female gametes, quantum dots have proved to be cytotoxic, consequently negatively
influencing oocyte maturation and fertilization [26].
2.3. Micronuclei Formation in Granulosa Cells after Incubation with SPION
Micronuclei tests are used in toxicological screening to identify genotoxic substances according
to OECD guidelines. Micronuclei are small cytoplasmic bodies formed in anaphase of mitosis or
meiosis. They contain pieces of chromosomes, resulting in a lack of DNA information in one daughter
cell. In microscopy, they can be recognized as small nuclei separate from the main nucleus and
are enclosed in their own nuclear membrane. An augmented frequency of micronuclei serves as a
biomarker for genotoxicity [27,28].
Because of their small size some nanoparticles can easily penetrate through membranes directly
to the nucleus. Here, they can interact with the DNA and thus being a potential genotoxic hazard [29].
Different concentrations (as indicated) of iron oxide nanoparticles SEONLA-BSA, SEONDEX and
SEONLA were incubated with granulosa cells and analyzed for micronuclei formation after 48 h
(Figures 3 and 4) and 72 h (data not shown) using flow cytometry and fluorescence microscopy. Flow
cytometry analysis revealed no remarkable difference in the micronuclei number of SEONDEX and
SEONLA-BSA treated cells as compared to the untreated control (Figure 3). Whereas, for SEONLA
induction of micronuclei was 0.12-fold higher on average compared to control. This was confirmed
via fluorescence microscopy (Figure 4). Vinblastine, which causes M phase specific cell cycle arrest by
disrupting microtubule association (not shown), and the topoisomerase IIα inhibitor etoposide were
used as positive controls to induce micronuclei formation. So far, it is not clear whether cytotoxicity
caused by high concentrations of SEONLA is a secondary effect of DNA damage and will have to be
further investigated.
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Figure 3. Flow cytometry of micronuclei in HLG-5 cells. Cells were treated with 50, 100 or 150 μg/mL 
iron oxide nanoparticles. Etoposide-treated cells served as positive control; mock treated cells served 
as negative control. After 48 h flow cytometry analysis using ethidium monoazide (EMA)/SYTOX 
green staining revealed no increase in micronuclei induction for SEONLA-BSA and SEONDEX compared 
to the control (* p < 0.01, n = 3). 
Figure 3. Flow cytometry of micronuclei in HLG-5 cells. Cells were treated with 50, 100 or
150 µg/mL iron oxide nanoparticles. Etop side-tre ted cells s rved as p sitive control; mock treated
cells serv d as e ati e co trol. After 48 h flow cytometry analysis using ethidiu monoazide
(EMA)/SYTOX green staining revealed no increase in micronuclei induction for SEONLA-BSA and
SEONDEX compared to the control (* p < 0.01, n = 3).
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Figure 4. Fluorescence microscopy of micronuclei in HLG-5 cells. HLG-5 cells were treated for 48 h with 
50, 100 and 150 μg/mL SEONLA, SEONLA-BSA and SEONDEX, then DNA was stained with SYTOX green; 
SEONLA-BSA and SEONDEX showed no effect on cell morphology, whereas SEONLA-treated cells 
appeared unhealthy compared to control. Many micronuclei can be recognized in etoposide-treated 
cells; (scale bars = 20 μm, representative pictures are displayed; n = 3). 
2.4. DNA Damage in Granulosa Cells after Incubation with SPION 
Since micronuclei formation can be caused by DNA double strand breaks, this was evaluated by 
detection of phosphorylated H2A.X (Ser139) and ATM (Ser1981). The topoisomerase IIα inhibitor 
etoposide is a very effective inductor of DNA double strand breaks, and brings cells into G2/M phase 
cell cycle arrest [30]. Following DNA double strand breaks, cell cycle checkpoint arrest and DNA 
repair requires phosphorylation of histone H2A.X at serine 139 by kinases such as ataxia 
telangiectasia mutated (ATM). Therefore, the phosphorylation of H2A.X (γ-H2A.X) and ATM 
(pATM) is an important indicator of DNA damage [31]. 
Treatment of granulosa cells for 48 h with SEONLA , SEONLA-BSA and SEONDEX did not lead to 
phosphorylation of H2A.X or ATM compared to control cells, here summarized as “DNA damage” 
(Figure 5). This was also verified by western blot analysis (data not shown).  
Different sources of DNA damage (exogen, endogen, mechanical) can cause a variety of DNA 
lesions and can thus induce various cellular reactions including cell cycle arrest, apoptosis and 
notably, DNA repair. DNA double strand breaks are supposed to be the furthermost disastrous forms 
of DNA destruction, conceding genomic stability. Therefore, it is very important to ensure 
nanoparticles safety upon DNA damage [32]. 
Figure 4. Fluorescence microscopy of micronuclei in HLG-5 cells. HLG-5 cells were treated for
48 h with 50, 100 and 150 µg/mL SEONLA, SEONLA-BSA and SEONDEX, then DNA was stained
with SYTOX green; SEONLA-BSA and SEONDEX showed no effect on cell morphology, whereas
SEONLA-treated cells appeared unhealthy compared to control. Many micronuclei can be recognized
in etoposide-treated cells; (scale bars = 20 µm, representative pictures are displayed; n = 3).
2.4. DNA Damage in Granulosa Cells after Incubation with SPION
Since micronuclei formation can be caused by DNA double strand breaks, this was evaluated by
detection of phosphorylated H2A.X (Ser139) and ATM (Ser1981). The topoisomerase IIα inhibitor
etoposide is a very effective inductor of DNA double strand breaks, and brings cells into G2/M
phase cell cycle arrest [30]. Following DNA double strand breaks, cell cycle checkpoint arrest and
DNA repair requires phosphorylation of histone H2A.X at serine 139 by kinases such as ataxia
telangiectasia mutated (ATM). Therefore, the phosphorylation of H2A.X (γ-H2A.X) and ATM (pATM)
is an important indicator of DNA damage [31].
Treatment of granulosa cells for 48 h with SEONLA , SEONLA-BSA and SEONDEX did not lead to
phosphorylation of H2A.X or ATM compared to control cells, here summarized as “DNA damage”
(Figure 5). This was also verified by western blot analysis (data not shown).
Different sources of DNA damage (exogen, endogen, mechanical) can cause a variety of DNA
lesions and can thus induce various cellular reactions including cell cycle arrest, apoptosis and
notably, DNA repair. DNA double strand breaks are supposed to be the furthermost disastrous
forms of DNA destruction, conceding genomic stability. Therefore, it is very important to ensure
nanoparticles safety upon DNA damage [32].
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Figure 5. DNA damage (phosphorylation of H.2AX and ATM) in HLG-5 cells. Cells were incubated
for 48 h with 50, 100 and 150 µg/mL SEONLA, SEONLA-BSA and SEONDEX. Mock treated cells served
as negative controls; etoposide-treated cells served as positive controls (* p < 0.01, n = 3).
3. Experimental Section
3.1. Nanoparticles
All iron oxide nanoparticles used were comprehensively physico-chemically characterized
previously by Zaloga et al., and Unterweger et al. [10,18]. Briefly, superparamagnetic iron
oxide nanoparticles (SPIONs) were synthetized by co-precipitation in aqueous media (core size
7.64 ˘ 1.6 nm) and subsequent in-situ coating with lauric acid (LA), resulting in SEONLA to form
a stable colloid. They were then additionally coated with bovine serum albumin (BSA) by dilution in
excess protein solution and following removal of the unbound protein by ultrafiltration, resulting in
SEONLA-BSA [10,33]. Upon formation of a BSA protein corona the ζ potential decreased drastically,
indicating the high stability of aqueous dispersions of SEONLA-BSA. As expected, the surface charge
of the SEONLA-BSA particles was pH dependent, with the point of zero charge being just below pH 5
which is very consistent with the isoelectric point of BSA [10].
For the synthesis of SEONDEX, SPIONs were covered with dextran, the suspension was
ultrafiltrated, and particle-bound dextran finally crosslinked [18]. In SEONDEX particles (core
size 4.3 ˘ 0.9 nm) the dextran content during coprecipitation had an influence on the ζ potential.
Formation of a stable colloid was first achieved with 2.0 g of dextran with a ζ potential of
´2.0 ˘ 0.6 nm. SEONDEX show an agglomeration of roundish magnetite particles embedded in a
polymer matrix.
Synthesized SPIONs have a spherical morphology; Table 1 provides a summary of the basic
physico-chemical nanoparticle characteristics.
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Table 1. Basic physico-chemical properties of SEONLA, SEONLA-BSA and SEONDEX [10,18].
Physico-Chemical Properties of Nanoparticles SEONLA SEONLA-BSA SEONDEX
Core diameter (TEM) (nm) in H2O 7.64 ˘ 1.6 7.64 ˘ 1.6 4.3 ˘ 0.9
Hydrodynamic diameter (DLS) (nm) in RPMI 46.92 ˘ 0.1 61.7 ˘ 1.1 79 ˘ 1.3
ζ potential (mV) in RPMI ´15.5 ˘ 0.8 ´12.9 ˘ 0.55 ´2.0 ˘ 0.6
Polydispersity index in RPMI 0.331 ˘ 0.019 0.346 ˘ 0.028 0.304 ˘ 0.031
3.2. Cell Culture
Briefly, human luteinized granulosa cells, HLG-5 were collected from infertile women
undergoing In Vitro Fertilization (IVF) pre-embryo transfer treatment [34]. These cells duplicate every
48 h and were maintained in DMEM complemented with 10% fetal calf serum (FCS) (both Biochrom,
Berlin, Germany) under standard cell culture conditions in a humidified incubator (INCOmed,
Memmert, Schwabach, Germany) at 37 ˝C and 5% CO2. The cells were verified to be free of
mycoplasma. For the experiments, the cells were grown to a confluence of 75% and passaged twice a
week using 0.25% trypsin/0.02% EDTA in PBS (PAN Biotech, Aidenbach, Germany).
3.3. Live/Dead Staining Using Flow Cytometry
HLG-5 cells were seeded at a concentration of 2 ˆ 105 cells/ mL in 24 well plates. SEON
nanoparticles (50, 100 and 150 µg/mL) were added in 0.5 mL; mock treated cells served as controls.
After 24, 48, and 72 h the cells were trypsinized and resuspended in 1 mL DMEM. Fifty µL of
cell solution was incubated with 250 µL of freshly prepared staining solution, containing 1 µg/mL
Annexin V-Fitc (AxV-Fitc), 1 µg/mL Hoechst 33342 (Hoe), 5.1 µg/mL DiIC1(5) (Dil) (all from
Life Technologies, Darmstadt, Germany) and, 20 µg/mL propidium iodide ((PI), Sigma Aldrich,
Taufkirchen, Germany) in Ringer’s solution (Baxter Healthcare SA, Zurich, Switzerland) for 20 min
at 4 ˝C [23].
3.4. Micronuclei Test
For immunofluorescence staining the culture medium was withdrawn. After a washing step
with PBS (Sigma-Aldrich, St. Louis, MO, USA) and fixation with 3.7% formaldehyde (AppliChem,
Darmstadt, Germay) for 30 min, cells were permeabilized for 10 min with 0.5% Triton X-100
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany). Afterwards cells were incubated 30 min with
RNase (10 mg/mL, Sigma-Aldrich). Staining of the nuclei was achieved with SYTOX greenr for
20 min (1 µM, Life Technologies, Eugene, OR, USA). Once one step was finished, slides were washed
with PBS. Mounting medium was used to mount coverslips on glass slides (Dako North America, Inc.,
Carpinteria, CA, USA). The examination was made with a fluorescent microscope Axio Observer Z.1
with an ApoTome (Zeiss, Jena, Germany). Counting and recording of the micronuclei was performed
as stated by Tolbert et al. [35], with some alterations. Micronuclei are defined as: sphere-shaped forms
with a diameter of 1/3 to 1/20 of the central nucleus, micronuclei have to be in the same focus as the
nucleus, they should be completely disconnected from the main nucleus and appear with a related
shape of chromatin. For each sample set, 3000 cells were scored.
For flow cytometry analysis cells were trypsinized and centrifuged at 600 g for 5 min;
supernatant was discarded and cells were resuspended via moderate tapping. After adding
200 µL PBS with 2% heat-inactivated fetal bovine serum (FBS), the cells were transferred into tubes
containing 100 µL nucleic acid staining solution (125 mg/mL Ethidium monoazide in PBS with 2%
FBS); (EMA, Molecular Probes by Life Technologies). The tubes were cooled in an ice box and
photoactiviation was performed with a light source (60 W light bulb, Osram, Munich, Germany)
for 20 min and with 30 cm distance to the tubes. Following photoactivation, 800 µL of PBS with
2% FBS was supplemented and samples were transferred into 15 mL tubes with 8 mL PBS with 2%
FBS. From this point samples were protected from light. After centrifugation at 600 g for 5 min, the
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supernatant was discharged. The cells were resuspended by moderate tapping. 1 mL lysis solution 1
(deionized water, 0.584 mg/mL NaCl, 1 mg/mL sodium citrate, 0.3 µL/mL IGEPAL (Sigma-Aldrich),
1 mg/mL RNase and 0.2 µM SYTOX greenr was added slowly, the tubes were immediately vortexed
for 5 s and were set aside for 1 h at room temperature. Then lysis solution 2 (deionized water,
85.6 mg/mL sucrose, 15 mg/mL citric acid, and 0.2 µM SYTOX greenr) was added quickly, followed
by vortexing and kept at room temperature for another 30 min. Tubes were kept at 4 ˝C until flow
cytometric examination [36]. Tests for statistical significance were carried out using the Student’s
t-test in MS-Excel (Microsoft Corporation, Redmond, WA, USA).
3.5. DNA Damage Detection
HLG-5 cells were seeded at a concentration of 2 ˆ 105 cells/ mL in 12 well plates (TPP Techno
Plastic Products, Trasadingen, Switzerland). After 24 h, different SEON nanoparticles (50, 100 and
150 µg/mL) or 10 µM positive control (etoposide) were added in 1 mL; mock treated cells served
as controls. After 48 h and 72 h (data not shown) DNA double strand breaks were detected using
Muse™ Multi-Color DNA Damage Kit (Merck Millipore, Darmstadt, Germany) [37] by staining
1 ˆ 105 cells of each sample with anti-phospho-Histone H2A.X (Ser139) and anti-phospho-ATM
(Ser1981) antibodies. Samples were acquired on the Muse™ Cell Analyzer (Merck Millipore). Tests for
statistical significance were carried out using the Student’s t-test in MS-Excel (Microsoft Corporation).
3.6. Flow Cytometry
Flow cytometry was performed via a Gallios cytofluorometer (Beckman Coulter, Pasadena, CA,
USA). Electronic compensation was used to eliminate bleed over fluorescence. The data examination
was done with Kaluza software, version 1.2 (Beckman Coulter). All flow cytometry experiments were
conducted in triplicate, and the results were averaged.
3.7. Microwave Plasma–Atomic Emission Spectrometer (MP-AES)
For determination of absolute cellular iron content, 2 ˆ 106 cells were incubated with 150 µg/mL
nanoparticles. After 48 h the cells were washed, cell lysates were prepared from 1 ˆ 106 cells
and analyzed via Microwave Plasma–Atomic Emission Spectrometer, MP-AES 4200 (Agilent, Santa
Clara, CA, USA). The entire iron level was ascertained at an emission wavelength of 371.993 nm.
For calibration external standards of iron at concentrations reaching from 0.01 to 2.5 µg/mL were
utilized [38].
4. Conclusions
Little is known about the effects of nanoparticles on reproductive tissue and reproductively
relevant cells. Gametes and the embryo are rather vulnerable and are therefore located in a more
protected environment, but nanoparticles are most likely to cross these barriers, depending on
composition, size and/or coating [39,40]. As nanoparticles are already being used in clinics or in
clinical studies, they will be part of future medical applications, especially in diagnosis and therapy.
Hence, it is of greatest significance to ensure the safety also of reproductive tissue. According to
their field of application, e.g., contrast agents for diagnosis or as carriers of therapeutics in Magnetic
Drug Targeting (MDT), these particles are coated with different materials. As we found no uptake
of SEONDEX particularly in granulosa cells, they are considered to be suitable as contrast agents for
magnetic resonance imaging (MRI), because they will most likely remain longer within the blood
circulation. On the other hand, SEONLA-BSA with very low toxicity and low uptake can be used for
MDT in cancer or atherosclerosis therapy. In this study we demonstrated, that coating of iron oxide
nanoparticles is essential to ensure biocompatibility. Future studies are urgently needed to guarantee
the safe design of nanoparticles, especially for cells within reproductive tissues.
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